Cantitate/Preț
Produs

Progress in Cancer Immunotherapy: Advances in Experimental Medicine and Biology, cartea 909

Editat de Shuren Zhang
en Limba Engleză Paperback – 30 mai 2018
Thisbook provides readers an extensive overview of recent progress in basicand clinical research on cancer immunotherapy. Thanks to rapid advances inmolecular biology and immunology, it has become increasingly evident thatcancer growth is influenced by host immune responses. With the success of anumber of clinical trials, immunotherapy has become a promising treatmentmodality of cancer. This book covers five major topics, including monoclonalantibodies, biological response modifiers, cancer vaccines, adoptive cellulartherapy and oncolytic viruses. It also examines the combination of differentimmune strategies as well as the combination of immunotherapy with othertreatments to increase anti-tumor effects. Throughthecomprehensive discussion of the topic, the book sheds valuable new light on thetreatment of tumors.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 109425 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 30 mai 2018 109425 lei  6-8 săpt.
Hardback (1) 110121 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 6 iun 2016 110121 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 109425 lei

Preț vechi: 115184 lei
-5% Nou

Puncte Express: 1641

Preț estimativ în valută:
20941 21782$ 17288£

Carte tipărită la comandă

Livrare economică 14-28 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789402413793
ISBN-10: 9402413790
Ilustrații: XII, 283 p. 15 illus., 14 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.42 kg
Ediția:Softcover reprint of the original 1st ed. 2016
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:Dordrecht, Netherlands

Cuprins

Antibodytherapies in cancer.- Biological Response Modifier in Cancer Immunotherapy.- Progress and Development of Therapeutic Cancer Vaccines.- Adoptive Cellular Therapy(ACT) for Cancer Treatment.- OncolyticImmunotherapy for Treatment of Cancer​.

Notă biografică

Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy, and he has published more than 60 research articles in this field.

Textul de pe ultima copertă

Thisbook provides readers an extensive overview of recent progress in basicand clinical research on cancer immunotherapy. Thanks to rapid advances inmolecular biology and immunology, it has become increasingly evident thatcancer growth is influenced by host immune responses. With the success of anumber of clinical trials, immunotherapy has become a promising treatmentmodality of cancer. This book covers five major topics, including monoclonalantibodies, biological response modifiers, cancer vaccines, adoptive cellulartherapy and oncolytic viruses. It also examines the combination of differentimmune strategies as well as the combination of immunotherapy with othertreatments to increase anti-tumor effects. Throughthecomprehensive discussion of the topic, the book sheds valuable new light on thetreatment of tumors.

Caracteristici

Provides readers with recent progress in basic and clinical research of cancer immunotherapy Covers hot topics in cancer immunotherapy, such as cancer vaccines, monoclonal antibodies and adoptive cellular therapy Written by experts in this fields Includes supplementary material: sn.pub/extras